share_log

DermTech Analyst Ratings

DermTech Analyst Ratings

DermTech 分析師評級
Benzinga ·  2023/08/07 11:00
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 85.87% BTIG $6 → $5 Maintains Buy
03/29/2023 123.05% TD Cowen $8 → $6 Maintains Outperform
11/09/2022 85.87% Stephens & Co. $16 → $5 Maintains Overweight
11/08/2022 123.05% BTIG $15 → $6 Maintains Buy
11/04/2022 William Blair Downgrades Outperform → Market Perform
08/17/2022 755.02% Oppenheimer $48 → $23 Maintains Outperform
08/15/2022 457.62% BTIG $19 → $15 Maintains Buy
07/18/2022 1684.39% Oppenheimer → $48 Assumes → Outperform
01/07/2022 Stephens & Co. Initiates Coverage On → Overweight
05/03/2021 1870.26% BTIG → $53 Initiates Coverage On → Buy
01/22/2021 1870.26% Oppenheimer → $53 Initiates Coverage On → Outperform
10/30/2020 William Blair Initiates Coverage On → Outperform
09/10/2020 643.49% Cowen & Co. → $20 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
08/07/2023 85.87% BTIG 6 美元 → 5 美元 維護 購買
03/29/2023 123.05% TD Cowen 8 美元 → 6 美元 維護 跑贏大盤
11/09/2022 85.87% Stephens & Co. 16 美元 → 5 美元 維護 超重
2022 年 8 月 11 日 123.05% BTIG 15 美元 → 6 美元 維護 購買
2022 年 4 月 11 日 威廉布萊爾 降級 跑贏大盤 → 市場表現
08/17/2022 755.02% 奧本海默 48 美元 → 23 美元 維護 跑贏大盤
08/15/2022 457.62% BTIG 19 美元 → 15 美元 維護 購買
07/18/2022 1684.39% 奧本海默 → 48 美元 假設 → 跑贏大盤
2022 年 7 月 1 日 Stephens & Co. 啓動覆蓋開啓 → 超重
05/03/2021 1870.26% BTIG → 53 美元 啓動覆蓋開啓 → 購買
2021 年 1 月 22 日 1870.26% 奧本海默 → 53 美元 啓動覆蓋開啓 → 跑贏大盤
10/30/2020 威廉布萊爾 啓動覆蓋開啓 → 跑贏大盤
2020 年 10 月 9 日 643.49% Cowen & Co. → 20 美元 啓動覆蓋開啓 → 跑贏大盤

What is the target price for DermTech (DMTK)?

DermTech (DMTK) 的目標價格是多少?

The latest price target for DermTech (NASDAQ: DMTK) was reported by BTIG on August 7, 2023. The analyst firm set a price target for $5.00 expecting DMTK to rise to within 12 months (a possible 85.87% upside). 7 analyst firms have reported ratings in the last year.

BTIG於2023年8月7日公佈了DermTech(納斯達克股票代碼:DMTK)的最新目標股價。這家分析公司將目標股價定爲5.00美元,預計DMTK將在12個月內升至12個月內(可能上漲85.87%)。去年有7家分析公司公佈了評級。

What is the most recent analyst rating for DermTech (DMTK)?

分析師對DermTech(DMTK)的最新評級是多少?

The latest analyst rating for DermTech (NASDAQ: DMTK) was provided by BTIG, and DermTech maintained their buy rating.

DermTech(納斯達克股票代碼:DMTK)的最新分析師評級由BTIG提供,DermTech維持買入評級。

When is the next analyst rating going to be posted or updated for DermTech (DMTK)?

DermTech(DMTK)的下一個分析師評級何時公佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DermTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DermTech was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

分析師在進行了廣泛的研究(包括瀏覽公開財務報表、與DermTech的高管和客戶交談以及聽取業績電話會議)後得出股票評級。大多數分析師每三個月進行一次評級,因此每家公司每年應該獲得4個評級。DermTech的最後一次評級是在2023年8月7日提交的,因此您應該預計下一個評級將在2024年8月7日左右公佈。

Is the Analyst Rating DermTech (DMTK) correct?

分析師對 DermTech (DMTK) 的評級正確嗎?

While ratings are subjective and will change, the latest DermTech (DMTK) rating was a maintained with a price target of $6.00 to $5.00. The current price DermTech (DMTK) is trading at is $2.69, which is out of the analyst's predicted range.

雖然評級是主觀的,會發生變化,但最新的DermTech(DMTK)評級維持不變,目標股價爲6.00美元至5.00美元。DermTech(DMTK)目前的交易價格爲2.69美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論